Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Rita Pasold"'
Autor:
William Krüger, Carsten Hirt, Gottfried Dölken, Dietger Niederwieser, Matthias Schwenke, Rita Pasold, Michael Montemurro, Frank Schüler, Thomas Kiefer
Publikováno v:
Transfusion. 48:2624-2628
BACKGROUND: High-dose therapy with autologous stem cell support after standard dose induction is a promising approach for therapy of primary central nervous system lymphoma (PCNSL). High-dose methotrexate (HD-MTX) is a standard drug for induction of
Autor:
K. Bremer, P. Richter, Andreas Schwarzer, Chr. Müller, Rita Pasold, Manfred Schulze, Dietger Niederwieser, Chr. Klinkenstein, Klaus Dachselt, J. Weniger, C. Boewer, H. Arzberger, Mathias Freund, Antje Schulze, Cornelia Winkelmann, C. A. Müller, Veronika Schirmer, B. Ismer, Hans-Joerg Fricke, A. Franke, S. Hahnfeld, Michael Herold
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 132:105-112
Purpose: The purpose of this study was to compare the efficacy and toxicity of bendamustine, vincristine + prednisone (BOP) with a standard regimen of cyclophosphamide, vincristine + prednisone (COP) in patients with previously untreated advanced ind
Autor:
Joachim Brücher, Lars Fischer, Eckhard Thiel, Heinz Kirchen, Christian Peschel, Josef Birkmann, Rita Pasold, Dieter K. Hossfeld, Kristoph Jahnke, Agnieszka Korfel, Peter Martus, Matthias Stelljes, M. R. Nowrousian
Publikováno v:
British Journal of Haematology. 128:177-183
The majority of the available data on primary central nervous system lymphoma (PCNSL) derive from small unicentric or oligocentric studies. In this multicentre study, we evaluated the response, survival and toxicity in PCNSL patients after carmustine
Autor:
Rainer Krahl, Richard F. Schlenk, Rita Pasold, Thomas Büchner, Axel Benner, Dietger Niederwieser, Gerhard Heil, Jürgen Krauter, Hartmut Döhner, Cristina Sauerland, Markus Schaich, Brigitte Mohr, G. Ehninger, K Döhner, Arnold Ganser
Publikováno v:
Journal of Clinical Oncology. 22:3741-3750
Purpose To evaluate prognostic factors for relapse-free survival (RFS) and overall survival (OS) and to assess the impact of different postremission therapies in adult patients with core binding factor (CBF) acute myeloid leukemias (AML). Patients an
Autor:
Gerd Müller, Michael Koenigsmann, Rainer Bartsch, Christoph Kahl, Michael Herold, Henning Eschenburg, Martin Mohren, Kathleen Jentsch-Ullrich, Rita Pasold, Astrid Franke, Volker Lakner, W. U. Knauf, Michael Assmann
Publikováno v:
Leukemia & Lymphoma. 45:1821-1827
The therapy of patients with relapsed or refractory indolent lymphoma relies on the development of new drug combinations. The drugs bendamustine and fludarabine have cytotoxic activity as monotherapy in indolent lymphoma and show synergism in vitro.
Autor:
Kubel M, Hans-Joachim Schmoll, Rita Pasold, Michael Herold, Gottfried Dölken, F. Fiedler, Dietrich Kämpfe, Rainer Krahl, Luisa Mantovani, Wolfram Pönisch, Rita Subert, Dirk Hasenclever, W. Helbig, Dietger Niederwieser
Publikováno v:
Leukemia & Lymphoma. 43:265-274
Published randomized trials on different cytarabine doses for the treatment of acute myeloid leukemia (AML) provide evidence of a dose-response effect. However, high-dose cytarabine (HIDAC) regimens correlate with increased morbidity and toxicity rel
Autor:
A. Franke, Andreas Schwarzer, M. Herold, F. Fiedler, U von Grünhagen, J Doepper, G Dölken, Thoralf Lange, W Schultze, Cornelia Winkelmann, Hoffmann Fa, Erika Kettner, Elvira Edel, R. Uhle, Dietger Niederwieser, Sabine Leiblein, E Schwalbe, R. Krahl, Wolfram Pönisch, Rita Subert, Klaus Dachselt, Rita Pasold, Michael W. Deininger, W. Helbig, J. Steglich, M. Freund, P. Richter
Publikováno v:
Bone Marrow Transplantation. 27:1125-1132
Mobilised peripheral blood stem cells are widely used for autografting in patients with chronic myeloid leukaemia (CML) and it is generally thought that a high proportion of Ph-negative progenitor cells in the graft is desirable. We report here the r
Autor:
H. Eschenburg, Hans-Heinrich Wolf, Hoffmann Fa, M. Aßmann, H.-J. Hurtz, Wolfgang Knauf, Michael Herold, Astrid Franke, U. von Grünhagen, J. Ströhl, Rita Pasold, Dieter Huhn, S. Hahnfeld, Chr. Klinkenstein, M. Freund, J. Steglich
Publikováno v:
Oncology Research and Treatment. 23:164-166
Background: Phase I and II studies utilizing the chimeric anti-CD 20 antibody rituximab demonstrate good results in relapsed and resistant follicular and low-grade lymphoma; in combination with cyclophosphamide, doxorubicin, vincristine, and predniso
Autor:
Axel Glasmacher, Hans-Heinrich Wolf, Rita Pasold, Reinhard Andreesen, Hartmut Bertz, Andrew J. Ullmann, Heinrich Bodenstein, Christian Junghanss, Hannes Wandt, Mathias Hänel, Christian Boewer, Ulrich Wedding, Oliver A. Cornely, Gottfried Dölken
Publikováno v:
The Journal of antimicrobial chemotherapy. 57(2)
OBJECTIVES: This trial studied the efficacy and safety of itraconazole and fluconazole in the prevention of invasive fungal infections in neutropenic patients with haematological malignancies. PATIENTS AND METHODS: An 8 week, open-label, randomized,
Autor:
A. Bittrich, Antje Schulze, B. Harksel, Michael Assmann, Norbert Grobe, Mathias Freund, G. Wilhelm, P. Richter, E. Stelzer, K. Merkle, Th. Friedrich, Dietger Niederwieser, R. Šubert, Rita Pasold, Manfred Schulze, W. Helbig, Michael Herold, Klaus Dachselt, Paris S. Mitrou, Veronika Schirmer, Wolfram Pönisch
Publikováno v:
Journal of cancer research and clinical oncology. 132(4)
Purpose: This randomized phase III study compared bendamustine and prednisone (BP) to standard melphalan and prednisone (MP) treatment in previously untreated patients with multiple Myeloma (MM). Patients and Methods: To be included, patients had to